Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá
openFakultná nemocnica s poliklinikou Žilina · 17335825
Value
€948k
Published
9 Oct 2026
Deadline
9 Nov 2026, 07:00 GMT · 11d left · as published, verify on the notice
Type
opportunity · framework
33652000 · Medical equipment, pharmaceuticals & personal careSK031
Description
Trastuzumab sol inj 1x5 ml/600 mg 200 Pertuzumab con inf 1x420 mg 75 Trastuzumab-emtanzín plc ifc 1x100 mg 115 Trastuzumab-emtanzín plc ifc 1x160 mg 25 Pertuzumab and trastuzumab sol inj 1x15 ml/1200 mg/600 mg 10 Pertuzumab and trastuzumab sol inj 1x10 ml/600 mg/600 mg 185 Bevacizumab con inf 1x4 ml/100 mg 75 neregistrovaná očná indikácia
Key facts
- Procedure
- open
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Contact
- uvo@fnspza.sk
- Bids opened
- 9 Nov 2026, 08:00 GMT
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 699237-2026
- First seen
- 9 Oct 2026
- Last updated
- 9 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/2bad4d89-42a8-4414-b154-4b94da798590The source notice is authoritative — verify deadlines and documents there before bidding.